Ketamine Worth Rs 8 Crore Seized In Mumbai; Two Held

MUMBAI : After raiding a commercial unit on Thursday, the Mumbai police recovered ketamine and strips of a banned drug collectively worth nearly Rs 8.50 crore, an official said.

Two persons were arrested in connection with the seizure from the premises in suburban Andheri.

According to the crime branch official, acting on reliable information, the Anti-Extortion Cell (AEC) of the Mumbai police raided the commercial unit and recovered 15.743 kg of ketamine worth Rs 7.87 crore and 23,410 strips of a banned drug valued at Rs 58,31,500.

The police were trying to get more details about the arrested accused and to whom they were going to supply the drugs, he said. The duo was booked under relevant sections of the NDPS Act and further investigation was underway, the official added.

  • Related Posts

    AbbVie loses patent plea for Hep C drug

    New Delhi: The Indian Patent Office has refused to grant a secondary patent to AbbVie for its blockbuster Hepatitis C drug combination glecaprevir/pibrentasvir, sold globally under the brand name Maviret.…

    GSK’s Calpol a well-known trademark: High Court

    New Delhi: In a relief to UK-headquartered GlaxoSmithKline Pharmaceuticals (GSK), the Delhi High Court has declared its pain and fever medicine ‘Calpol’ as a well-known trademark that has acquired extensive…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    AbbVie loses patent plea for Hep C drug

    AbbVie loses patent plea for Hep C drug

    GSK’s Calpol a well-known trademark: High Court

    GSK’s Calpol a well-known trademark: High Court

    3 arrested for allegedly posing as doctors using forged MBBS degrees

    3 arrested for allegedly posing as doctors using forged MBBS degrees

    Commissioner FDA reviews enforcement measures

    Commissioner FDA reviews enforcement measures

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

    Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer